Abstract
This paper discusses the development of the biotechnology industry in an Italian region, Lombardy. It asks why significant innovative activities in biotechnology did not emerge in what might have been considered at the outset a promising area for the growth of this industry and why in very recent years some timid symptoms of dynamism seem to be appearing. After an overview of the patterns of the development of biotechnology in Italy, the specific case of Lombardy, is described. Then, the paper discusses what kind of factors might explain the lagging behind of the Italian (and more generally, European) biotechnology industry vis-à-vis the United States.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Arora, A. and A. Gambardella, 1990, 'Complementarity and External Linkage: The Strategies of the Large Firms in Biotechnology' Journal of Industrial Economics 37(4), 361-379.
Audretsch, D. and M. Feldman, 1996, 'R&D Spillovers and the Geography of Innovation and Production' American Economic Review 86(3), 630-640.
Audretsch, D.B. and P. Stephan, 1996, 'Company — Scientist Locational Links: The Case of Biotechnology' American Economic Review 86(3), 641-652.
Ben-David, J., 1976, Centers of Learning —Britain, France, Germany, United States, New York: McGraw-Hill Company.
Braun, D., 1994, Structure and Dynamics of Health Research and Public Funding, Dordrecht, The Netherlands: Kluwer.
Clark, B. R., 1995, Places of Inquiry —Research and Advanced Education in Modern Universities, Berkeley: University of California Press.
Cancogni, E., 1998, Relazioni Pericolose. I Rapporti Università-Industria in Italia, Bocconi University.
Casper, S., 1999, National Institutional Framework and High-Technology Innovation in Germany: The Case of Biotechnology, Wissenschaftszentrum, Berlin, mimeo.
Cesaroni, F., M. Cioppi and A. Gambardella, 1995, 'Pure, Willing and Entrepreneur: Industrial Transferability and Italian Scientists in Molecular Biology' in P. David and E. Steinmueller (eds.), A Productive Tension: University-Industry Research Collaborations in the Era of Knowledge-Based Economic Development, Stanford: Stanford University Press.
Cockburn, I. and R. Henderson, 1996, 'Public-Private Interaction in Pharmaceutical Research' Proceedings of the National Academy of Sciences 93/23 (November 12), pp. 12725-12730.
Cockburn, I., R. Henderson and S. Stern, 1997, 'Fixed Effects and the Diffusion of Organizational Practice in Pharmaceutical Research' MIT, Mimeo.
Gambardella, A., 1995, Science and Innovation in the U.S. Pharmaceutical Industry, Cambridge: Cambridge University Press.
Henderson, R., 1994, 'The Evolution of Integrative Competence: Innovation in Cardiovascular Drug Discovery' Industrial and Corporate Change 3(3), 607-630.
Henderson, R. and I. Cockburn, 1994, 'Measuring Competence? Exploring Firm Effects in Pharmaceutical Research' Strategic Management Journal 15, 63-84.
Henderson, R. and I. Cockburn, 1996, 'Scale, Scope and Spillovers: The Determinants of Research Productivity in Drug Discovery' Rand Journal of Economics 27(1), Spring, 32-59.
Henderson, R., L. Orsenigo and G. Pisano, 1999, 'The Pharmaceutical Industry and the Revolution in Molecular Biology: Exploring the Interactions Between Scientific, Institutional and Organizational Change' in D. Mowery and R. Nelson (eds.), The Sources of Industrial Advantages, Cambridge: Cambridge University Press.
Jaffe, A. B., M. Trajtenberg and R. Henderson, 1993, 'Geographic Localization of Knowledge Spillovers as Evidenced by Patent Citations' Quarterly Journal of Economics, August.
Mahdi, S. and K. Pavitt, 1997, 'Key National Factors in the Emergence of Computational Chemistry Firms' International Journal of Innovation Management.
Merges, R. and R. Nelson, 1994, 'On Limiting or Encouraging Rivalry in Technical Progress: The Effect of Patent Scope Decisions' Journal of Economic Behavior and Organization 25, 1-24.
Orsenigo, L., 1989, The Emergence of Biotechnology. Institutions and Markets in Industrial Innovation, London: Pinter Publishers.
Orsenigo, L., 1991, 'Archipelago Europe — Islands of Innovation. The case of Italy', in Commission of the European Communities, FAST — MONITOR Project, FOP 243, Prospective Dossier N. 1: Science, Technology and Economic Cohesion in the Community, Vols. 20–21, Bruxelles.
Orsenigo, L. and E. Cancogni, 1999, 'Le Relazioni Università-Industria in Italia' in C. Antonelli (ed.), Conoscenza Tecnologica. Nuovi Paradigmi dell'Innovazione e Specificità Italiana, Torino: Edizione Fondazione Agnelli.
Orsenigo, L., F. Pammolli and M. Riccaboni, 1999, 'Technological Change and Network Dynamics. The case of the bio-pharmaceutical industry' Research Policy, 2001, forthcoming.
Pisano, G., 1996, 'The Governance of Innovation: Vertical Integration and Collaborative Arrangements in the Biotechnology Industry' Research Policy 20, 237-249.
Senker, J. (ed.), 1998, Biotechnology and Competitive Advantage, Edward Elgar.
Senker, J., P. B. Joly and M. Reinhard, 1998, 'Biotechnology and Europe's Chemical/Pharmaceutical multinationals' in J. Senker (ed.), Biotechnology and Competitive Advantage, Edward Elgar.
Sharp, M., 1985, 'The New Biotechnology: European Governments in Search of a Strategy' Brighton, Sussex European Papers, University of Sussex.
Swann, P., M. Prevezer and D. Stout (eds.), 1998, The Dynamics of Industrial Clustering, Oxford: Oxford University Press.
Teece, D. J., 1986, 'Profiting from Technological Innovation: Implications for Integration, Collaboration, Licensing and Public Policy' Research Policy 15(6), December.
Thomas, L.G., III, 1994, 'Implicit Industrial Policy: The Triumph of Britain and the Failure of France in Global Pharmaceuticals' Industrial and Corporate Change 3(2).
Zucker, L. G. and M. R. Darby, 1995, 'Present at the Revolution: Transformation of Technical Identity for a Large Incumbent Pharmaceutical Firm After the Biotechnological Breakthrough' Research Policy 26(4, 5), 429-447.
Zucker L. G., Darby M. R. and Brewer M., 1998a, 'Intellectual Human Capital and the Birth of U.S. Biotechnology Enterprises' American Economic Review 88(1), 290-306.
Zucker L. G., Darby M. R. and J. Armstrong, 1998b, 'Geographically Localised Knowledge: Spillovers or Markets?' Economic Inquiry 36, 65-86.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Orsenigo, L. The (Failed) Development of a Biotechnology Cluster: The Case of Lombardy. Small Business Economics 17, 77–92 (2001). https://doi.org/10.1023/A:1011122404765
Issue Date:
DOI: https://doi.org/10.1023/A:1011122404765